UAE-based Julphar, a leading generic pharmaceutical manufacturer in Middle East and North Africa (Mena) region, has appointed Jerome Carle as its new chief financial officer.

In his new role, Carle will be responsible for leading the company’s finance department and keeping accurate financial records, said a statement from the company.

Moreover, he will be in charge of the administrative and risk management operations and will develop financial strategies in line with the company’s objectives, and will report to the Julphar’s CEO, Dr Ayman Sahli, it said.

Carle has over 20 years of financial expertise in emerging markets, and his broad and international experience shows his ability to adapt and deliver results in global and challenging environments.

He has proven expertise in the pharmaceutical industry, having served in the most reputable companies in both fields, with a full hand responsibility on the financial operations, supply chain and internal control administration.

Sheikh Faisal Bin Saqr Al Qasimi, chairman of Julphar, said: “I am very pleased to welcome Carle on board.”

“He is an established financial executive, and I strongly believe his significant and broad international experience will make an immediate impact to the team to execute our business plan and play a part in the company’s success,” he said.

Speaking on his appointment, Carle said: “I am very proud, honoured and excited to join the Julphar family.”

“The company is positioned to be a major player in the pharmaceutical industry with an attractive regional footprint, as it produces a strong portfolio of high quality, affordable products,” he added.

“I am confident that we can foresee significant growth, and I am delighted to be a part of it,” he concluded. – TradeArabia News Service